Pfizer's Reorganizing Again. Is Its Stock A Buy Now?

Last week, Pfizer (NYSE: PFE) announced that it was splitting its operating segments into three divisions. The company presently operates under a two-unit system: Innovative Health and Essential Health. Soon, however, it will instead sport an Innovative Medicines business, an Established Medicines unit, and a Consumer Healthcare segment. As this second reorganization in four years seems like a prelude to additional business development moves, this is an opportune time to consider if this big pharma stock is worth buying.  Image Source: Getty Images.Continue reading

BING NEWS:
  • The Cleanfluencers Who Declutter, Haul, Restock, Repeat
    Meet the content creators making a living by cleaning and reorganizing, one purse tower, acrylic plastic container, and egg organizer at a time.
    04/10/2024 - 1:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News